Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 3496 AL 3510

Non-dopamine receptor ligands for the treatment of Parkinson's disease. Insight into the related chemical/property space

Ivanenkov YA, Veselov MS, Chufarova NV, Majouga AG, Kudryavceva AA, Ivachtchenko AV.

Mol Divers. 2016 Feb;20(1):345-65. doi: 10.1007/s11030-015-9598-y. Epub 2015 May 9.

A meta-analysis on relationship of MAOB intron 13 polymorphisms, interactions with smoking/COMT H158L polymorphisms with the risk of PD

Zhang Y, Piao X, Wu J, Li Y, Liang Q.

Int J Neurosci. 2016;126(5):400-7. doi: 10.3109/00207454.2015.1028057. Epub 2015 Jul 20.

Lack of association between the ATP13A2 A746T variant and Parkinson's disease susceptibility in Han Chinese: a meta-analysis

Pan LS, Wang Z, Ding D, Zhu XP, Leng HL, Deng XB, Xu YM.

Int J Neurosci. 2016;126(7):593-9. doi: 10.3109/00207454.2015.1035377. Epub 2015 Jun 5.

Cognitive profile of Parkinson's disease patients: a comparative study between early-onset and late-onset Parkinson's disease

Tang H, Huang J, Nie K, Gan R, Wang L, Zhao J, Huang Z, Zhang Y, Wang L.

Int J Neurosci. 2016;126(3):227-34. doi: 10.3109/00207454.2015.1010646. Epub 2015 May 22.

Olfaction deterioration in cognitive disorders in the elderly

Ottaviano G, Frasson G, Nardello E, Martini A.

Aging Clin Exp Res. 2016 Feb;28(1):37-45. doi: 10.1007/s40520-015-0380-x. Epub 2015 May 24.

The human cytomegalovirus non-coding Beta2.7 RNA as a novel therapeutic for Parkinson's disease--Translational research with no translation

Poole E, Kuan WL, Barker R, Sinclair J.

Virus Res. 2016 Jan 2;212:64-9. doi: 10.1016/j.virusres.2015.05.007. Epub 2015 May 21.

Impaired capacity for prospection in the dementias--Theoretical and clinical implications

Irish M, Piolino P.

Br J Clin Psychol. 2016 Mar;55(1):49-68. doi: 10.1111/bjc.12090. Epub 2015 May 27.

N-3 polyunsaturated fatty acids in animal models with neuroinflammation: An update

Trépanier MO, Hopperton KE, Orr SK, Bazinet RP.

Eur J Pharmacol. 2016 Aug 15;785:187-206. doi: 10.1016/j.ejphar.2015.05.045. Epub 2015 May 30.

Visual cues combined with treadmill training to improve gait performance in Parkinson's disease: a pilot randomized controlled trial

Schlick C, Ernst A, Bötzel K, Plate A, Pelykh O, Ilmberger J.

Clin Rehabil. 2016 May;30(5):463-71. doi: 10.1177/0269215515588836. Epub 2015 Jun 2.

L-type calcium channels as drug targets in CNS disorders

Ortner NJ, Striessnig J.

Channels (Austin). 2016;10(1):7-13. doi: 10.1080/19336950.2015.1048936. Epub 2015 Jun 3.

Intermanual transfer in an artist with Parkinson's disease

Kho KH, Janssen N.

Neurocase. 2016;22(1):119-21. doi: 10.1080/13554794.2015.1053492. Epub 2015 Jun 8.

Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer

Ferré S, Bonaventura J, Tomasi D, Navarro G, Moreno E, Cortés A, Lluís C, Casadó V, Volkow ND.

Neuropharmacology. 2016 May;104:154-60. doi: 10.1016/j.neuropharm.2015.05.028. Epub 2015 Jun 4.

Obstructive sleep apnea in Parkinson's disease patients: effect of Sinemet CR taken at bedtime

Gros P, Mery VP, Lafontaine AL, Robinson A, Benedetti A, Kimoff RJ, Kaminska M.

Sleep Breath. 2016 Mar;20(1):205-12. doi: 10.1007/s11325-015-1208-9. Epub 2015 Jun 13.

Finger force changes in the absence of visual feedback in patients with Parkinson's disease

Jo HJ, Ambike S, Lewis MM, Huang X, Latash ML.

Clin Neurophysiol. 2016 Jan;127(1):684-692. doi: 10.1016/j.clinph.2015.05.023. Epub 2015 Jun 3.

Effects of a Single Hand-Exercise Session on Manual Dexterity and Strength in Persons with Parkinson Disease: A Randomized Controlled Trial

Mateos-Toset S, Cabrera-Martos I, Torres-Sánchez I, Ortiz-Rubio A, González-Jiménez E, Valenza MC.

PM R. 2016 Feb;8(2):115-22. doi: 10.1016/j.pmrj.2015.06.004. Epub 2015 Jun 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias